Johnson finished Saturday's 115-113 loss to the Celtics with 21 points (8-15 FG, 5-9 3Pt), six rebounds, two assists and one steal over 31 minutes. Johnson registered his eighth game of the season ...
Johnson & Johnson JNJ reported its first-quarter results ahead of expectations, with the beat driven by higher sales from its ...
Johnson & Johnson stock was falling even after the multinational pharmaceutical giant posted better-than-expected earnings for the fourth quarter. Adjusted earnings of $2.46 a share were better than ...
Johnson & Johnson's Q1 2025 earnings show a 2.4% sales increase and a significant EPS rise, despite litigation charges impacting GAAP figures. The MedTech division grew 4.1%, driven by acquisitions, ...
Johnson & Johnson JNJ reported third-quarter results slightly ahead of consensus, inching up full-year guidance for reported revenue growth by 30 basis points to 5.7% at the midpoint while maintaining ...